Aperçu des produits pour anti-CD137 (TNFRSF9) Anticorps

Full name:
anti-Tumor Necrosis Factor Receptor Superfamily, Member 9 Anticorps (TNFRSF9)
Chez www.anticorps-enligne.fr sont 326 Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) Anticorps de 23 de différents fournisseurs disponibles. De plus, nous expédions CD137 Protéines (62) et CD137 Kits (28) et beaucoup plus de produits pour cette protéine. Un total de 426 CD137 produits sont actuellement listés.
Synonymes:
4-1BB, A930040I11Rik, AA408498, AI325004, Cd137, CDw137, ILA, Ly63, TNFRSF9, zgc:136557
afficher tous les anticorps Gène GeneID UniProt
TNFRSF9 3604 Q07011
TNFRSF9 21942 P20334
TNFRSF9    

Afficher toutes les espèces

Afficher tous les synonymes

Réactivités les plus populaires pour anti-CD137 (TNFRSF9) Anticorps

Sélectionnez vos espèces et l'application

anti-Human CD137 Anticorps:

anti-Mouse (Murine) CD137 Anticorps:

anti-Rat (Rattus) CD137 Anticorps:

Tous anti-CD137 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-CD137 Anticorps mieux référencés

  1. Human Monoclonal CD137 Primary Antibody pour FACS, IF - ABIN2663017 : Alderson, Smith, Tough, Davis-Smith, Armitage, Falk, Roux, Baker, Sutherland, Din: Molecular and biological characterization of human 4-1BB and its ligand. dans European journal of immunology 1994 (PubMed)
    Show all 8 references for 2663017

  2. Human Monoclonal CD137 Primary Antibody pour FACS - ABIN2665542 : Schwarz, Blanco, von Kempis, Valbracht, Lotz: ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. dans Blood 1996 (PubMed)
    Show all 8 references for 2665542

  3. Human Monoclonal CD137 Primary Antibody pour FACS - ABIN2657240 : Gruss, Dower: Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. dans Blood 1995 (PubMed)
    Show all 8 references for 2657240

  4. Human Monoclonal CD137 Primary Antibody pour FACS - ABIN2660941 : Sica, Chen: Modulation of the immune response through 4-1BB. dans Advances in experimental medicine and biology 2000 (PubMed)
    Show all 8 references for 2660941

  5. Human Monoclonal CD137 Primary Antibody pour Func, FACS - ABIN610408 : Boulton, Cobb: Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. dans Cell regulation 1991 (PubMed)
    Show all 4 references for 610408

  6. Human Polyclonal CD137 Primary Antibody pour IF (p), IHC (p) - ABIN740445 : Daquinag, Tseng, Salameh, Zhang, Amaya-Manzanares, Dadbin, Florez, Xu, Tong, Kolonin: Depletion of white adipocyte progenitors induces beige adipocyte differentiation and suppresses obesity development. dans Cell death and differentiation 2014 (PubMed)
    Show all 2 references for 740445

  7. Human Polyclonal CD137 Primary Antibody pour ELISA (Detection), FACS - ABIN4899793 : Lindstedt, Johansson-Lindbom, Borrebaeck: Expression of CD137 (4-1BB) on human follicular dendritic cells. dans Scandinavian journal of immunology 2003 (PubMed)

  8. Human Polyclonal CD137 Primary Antibody pour ELISA, WB - ABIN1533841 : Schwarz, Tuckwell, Lotz: A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family. dans Gene 1994 (PubMed)

Plus d’anticorps contre CD137 partenaires d’interaction

Human Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) interaction partners

  1. Egr2 (Montrer EGR2 Anticorps)-driven cell surface proteins LAG-3 (Montrer LAG3 Anticorps) and 4-1BB can identify dysfunctional tumor antigen-specific CD8 (Montrer CD8A Anticorps)(+) TIL (Montrer TLR1 Anticorps).

  2. Findings indicate that CD137 antigen is a useful marker that can be used for identifying Mycobacterium tuberculosis (Mtb (Montrer NCAPG2 Anticorps))-reactive CD4 (Montrer CD4 Anticorps)(+) T cells (Mtb (Montrer NCAPG2 Anticorps)-reactive CD4 (Montrer CD4 Anticorps)(+) T cells) by flow cytometry.

  3. Anti-4-1BB single chain variable fragments enhanced surface CD69 (Montrer CD69 Anticorps) expression and interleukin-2 (Montrer IL2 Anticorps) production in stimulated CCRF-CEM cells which confirmed the agonistic effect of the selected single chain variable fragments. The data from this study have provided a rationale for further experiments involving the biological functions of anti-4-1BB single chain variable fragments in future studies.

  4. Studies suggest that adoptive T cell therapy and CD137 antigen offer much opportunity to raise the efficacy of current cancer immunotherapies.

  5. Triple costimulation via CD80 (Montrer CD80 Anticorps), 4-1BB, and CD83 (Montrer CD83 Anticorps) ligand elicits the long-term growth of Vgamma9Vdelta2 T cells in low levels of IL-2 (Montrer IL2 Anticorps).

  6. These studies provide the first direct evidence that ligation of tumour necrosis factor (Montrer TNF Anticorps) superfamily members and their cognate receptors is important for the control of viral lytic replication.

  7. Our findings provide a novel, TNFRSF9-positive, reactive astrocytic phenotype in human gliomas

  8. Human genetic evidence for involvement of CD137 in atherosclerosis

  9. As a result of becoming activated, transferred human T lymphocytes express the inducible surface antigens hPD-1 (Montrer PDCD1 Anticorps) and hCD137 on their plasma membrane.

  10. Our results provide biological explanations for the antitumor effects of CD19 (Montrer CD19 Anticorps) CARs and for the observations that CD19 (Montrer CD19 Anticorps) CAR T cells incorporating the 4-1BB costimulatory domain are more persistent than those incorporating CD28 (Montrer CD28 Anticorps) in clinical trials.

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) interaction partners

  1. results indicate that one important diabetogenic function of CD137 is to promote the expansion and accumulation of beta cell-autoreactive CD8 (Montrer CD8A Anticorps) T cells, and in the absence of CD137 or its interaction with CD137 ligand, type 1 diabetes progression is suppressed

  2. High CD137 expression is associated with neoplasms.

  3. Ly6C, 4-1BB, and KLRG1 (Montrer KLRG1 Anticorps) have roles in the activation of lamina propria lymphocytes in the small intestine in a mouse model of Crohn's disease

  4. CD137 Regulates NFATc1 (Montrer NFATC1 Anticorps) Expression in Mouse VSMCs through TRAF6 (Montrer TRAF6 Anticorps)/NF-kappaB (Montrer NFKB1 Anticorps) p65 (Montrer NFkBP65 Anticorps) Signaling Pathway.

  5. 4-1BB triggering preferentially enhances the expansion of CD8 (Montrer CD8A Anticorps)+ T cells through the amplification of autocrine IL-2 (Montrer IL2 Anticorps)/IL-2R signaling loop.

  6. c-IAP (Montrer ALPI Anticorps) ubiquitin protein ligase (Montrer UBE2K Anticorps) activity is required for 4-1BB signaling and CD8 (Montrer CD8A Anticorps)(+) memory T-cell survival.

  7. we conclude that in vivo 4-1BB signaling of myeloid cells negatively regulates peripheral T cell responses

  8. activation of CD137 signaling decreases the stability of advanced atherosclerotic plaques via its combined effects on Teff cells, vascular smooth muscle cells, and macrophages

  9. 4-1BB mediates the inflammatory responses in obese skeletal muscle by interacting with its ligand 4-1BBL (Montrer TNFSF9 Anticorps) on macrophages.

  10. CD137-CD137L (Montrer TNFSF9 Anticorps) interactions mediated via regulation of CyPA (Montrer PPIA Anticorps) contribute to the progression of atherosclerosis.

CD137 (TNFRSF9) profil antigène

Antigen Summary

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contributes to the clonal expansion, survival, and development of T cells. It can also induce proliferation in peripheral monocytes, enhance T cell apoptosis induced by TCR/CD3 triggered activation, and regulate CD28 co-stimulation to promote Th1 cell responses. The expression of this receptor is induced by lymphocyte activation. TRAF adaptor proteins have been shown to bind to this receptor and transduce the signals leading to activation of NF-kappaB.

Alternative names and synonyms associated with CD137 (TNFRSF9)

  • tumor necrosis factor receptor superfamily, member 9 (TNFRSF9) anticorps
  • tumor necrosis factor receptor superfamily, member 9a (tnfrsf9a) anticorps
  • tumor necrosis factor receptor superfamily, member 9 (LOC100348914) anticorps
  • tumor necrosis factor receptor superfamily, member 9 (Tnfrsf9) anticorps
  • 4-1BB anticorps
  • A930040I11Rik anticorps
  • AA408498 anticorps
  • AI325004 anticorps
  • Cd137 anticorps
  • CDw137 anticorps
  • ILA anticorps
  • Ly63 anticorps
  • TNFRSF9 anticorps
  • zgc:136557 anticorps

Protein level used designations for TNFRSF9

tumor necrosis factor receptor superfamily, member 9 , tumor necrosis factor receptor superfamily member 9 , 4-1BB ligand receptor , CD137 antigen , T cell antigen ILA , T-cell antigen 4-1BB homolog , T-cell antigen ILA , homolog of mouse 4-1BB , induced by lymphocyte activation (ILA) , interleukin-activated receptor, homolog of mouse Ly63 , receptor protein 4-1BB , T-cell antigen 4-1BB , secreted CD137 antigen

GENE ID SPECIES
419365 Gallus gallus
520341 Bos taurus
608274 Canis lupus familiaris
678622 Danio rerio
708281 Macaca mulatta
746029 Pan troglodytes
100196937 Papio anubis
100348914 Oryctolagus cuniculus
3604 Homo sapiens
21942 Mus musculus
Fournisseurs de qualité sélectionnés pour anti-CD137 (TNFRSF9) Anticorps
Avez-vous cherché autre chose?